{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:02:57Z","timestamp":1775570577357,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-07232-1","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:34:55Z","timestamp":1772714095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unexpected resolution of clozapine-induced obsessive\u2013compulsive symptoms with cariprazine augmentation: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Ismail","family":"Rammouz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"El Oumary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saliha","family":"Hamri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija","family":"Akebour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Mouhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalal","family":"Doufik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Boujraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"7232_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"7232_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.827744","volume":"13","author":"R Csehi","year":"2022","unstructured":"Csehi R, Dombi ZB, Sebe B, Moln\u00e1r MJ. Real-life clinical experience with cariprazine: a systematic review of case studies. Front Psychiatry. 2022;13: 827744. https:\/\/doi.org\/10.3389\/fpsyt.2022.827744.","journal-title":"Front Psychiatry"},{"key":"7232_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.816339","volume":"13","author":"P Czobor","year":"2022","unstructured":"Czobor P, Sebe B, Acsai K, et al. What is the minimum clinically important change in negative symptoms of schizophrenia? PANSS based post-hoc analyses of a phase III clinical trial. Front Psychiatry. 2022;13: 816339. https:\/\/doi.org\/10.3389\/fpsyt.2022.816339.","journal-title":"Front Psychiatry"},{"key":"7232_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/YIC.0000000000000284","volume":"35","author":"D De Berardis","year":"2020","unstructured":"De Berardis D, Vellante F, Fornaro M, Orsolini L, Valchera A, Baroni G, et al. Rapid improvement of obsessive-compulsive disorder associated with schizophrenia with cariprazine add-on in a subject under paliperidone long-acting injection: a case report. Int Clin Psychopharmacol. 2020;35:113\u20138. https:\/\/doi.org\/10.1097\/YIC.0000000000000284.","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"7232_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-12-40","volume":"12","author":"G Ery\u0131lmaz","year":"2013","unstructured":"Ery\u0131lmaz G, H\u0131zl\u0131 Sayar G, Ozten E, G\u00f6gceg\u00f6z G\u00fcl I, Karamustafal\u0131o\u011flu O. Aripiprazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia. Ann Gen Psychiatry. 2013;12(1): 40. https:\/\/doi.org\/10.1186\/1744-859X-12-40.","journal-title":"Ann Gen Psychiatry"},{"issue":"5","key":"7232_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1192\/bjp.2024.30","volume":"224","author":"E Fernandez-Egea","year":"2024","unstructured":"Fernandez-Egea E, Chen S, Sang\u00fcesa E, Gass\u00f3 P, Biria M, Plaistow J, Jarratt-Barnham I, Segarra N, Mas S, Ribate MP, Garc\u00eda CB, Fineberg NA, Worbe Y, Cardinal RN, Robbins TW. The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study. Br J Psychiatry. 2024;224(5):164\u20139. https:\/\/doi.org\/10.1192\/bjp.2024.30.","journal-title":"Br J Psychiatry"},{"issue":"11","key":"7232_CR7","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The yale-brown obsessive compulsive scale: I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006\u201311. https:\/\/doi.org\/10.1001\/archpsyc.1989.01810110048007.","journal-title":"Arch Gen Psychiatry"},{"key":"7232_CR8","doi-asserted-by":"publisher","unstructured":"G\u00fcrcan G , \u015eenol SH , A Ya\u011fc\u0131o\u011flu EA , Ertu\u011frul A . Clinical risk factors, phenomenology and the impact of clozapine induced obsessive compulsive symptoms. Psychiatry Res. 2021: 296:113665. https:\/\/doi.org\/10.1016\/j.psychres.2020.113665","DOI":"10.1016\/j.psychres.2020.113665"},{"key":"7232_CR9","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"W Guy","year":"1976","unstructured":"Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Department of Health, Education, and Welfare; 1976."},{"issue":"2","key":"7232_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261\u201376. https:\/\/doi.org\/10.1093\/schbul\/13.2.261.","journal-title":"Schizophr Bull"},{"issue":"3","key":"7232_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000505876","volume":"89","author":"DD Kim","year":"2020","unstructured":"Kim DD, Barr AM, Lu C, Stewart SE, White RF, Honer WG, Procyshyn RM. Clozapine-associated obsessive-compulsive symptoms and their management: a systematic review and analysis of 107 reported cases. Psychother Psychosom. 2020;89(3):151\u201360. https:\/\/doi.org\/10.1159\/000505876.","journal-title":"Psychother Psychosom"},{"key":"7232_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.psychres.2016.09.031","volume":"246","author":"DG Laroche","year":"2016","unstructured":"Laroche DG, Gaillard A. Induced obsessive compulsive symptoms (OCS) in schizophrenia patients under atypical 2 antipsychotics (AAPS)\u202f: review and hypothesis. Psychiatry Res. 2016;246:119\u201328. https:\/\/doi.org\/10.1016\/j.psychres.2016.09.031.","journal-title":"Psychiatry Res"},{"issue":"3","key":"7232_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0278-5846(03)00039-3","volume":"27","author":"L Lykouras","year":"2003","unstructured":"Lykouras L, Alevizos B, Michalopoulou P, Rabavilas AA. Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(3):333\u201346. https:\/\/doi.org\/10.1016\/S0278-5846(03)00039-3.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"7232_CR14","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852924000348","author":"V Martiadis","year":"2024","unstructured":"Martiadis V, Pessina E, Martini A, et al. Serotonin reuptake inhibitors augmentation with cariprazine in patients with treatment-resistant obsessive-compulsive disorder: a retrospective observational study. CNS Spectr. 2024. https:\/\/doi.org\/10.1017\/S1092852924000348.","journal-title":"CNS Spectr"},{"key":"7232_CR15","unstructured":"Martiadis V, Pessina E, Martini A, et al. Brexpiprazole augmentation in treatment-resistant OCD: safety and efficacy in an Italian sample. Psychiatria Danubina. 2024;36(Suppl 2):396\u2013401. https:\/\/hrcak.srce.hr\/en\/327275."},{"issue":"1","key":"7232_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12888-024-06466-9","volume":"25","author":"E Moreno Tarazona","year":"2025","unstructured":"Moreno Tarazona E, Gonzalez MO, La Rosa Giron A, Ruiz-Grosso P, Lazo-Porras M. Prevalence of obsessive-compulsive symptoms in patients with schizophrenia treated with clozapine: a scoping review. BMC Psychiatry. 2025;25(1):71. https:\/\/doi.org\/10.1186\/s12888-024-06466-9.","journal-title":"BMC Psychiatry"},{"key":"7232_CR17","doi-asserted-by":"publisher","unstructured":"Ouazzani Housni Touhami Y, Hlal H, Bout A, Najdi A, Aarab C, Rammouz I, Aalouane. Clinical profile of schizophrenia comorbid with obsessive-compulsive symptoms: A comparative study. Encephale. 2023;49(6):549\u2013556. https:\/\/doi.org\/10.1016\/j.encep.2022.07.002.","DOI":"10.1016\/j.encep.2022.07.002"},{"key":"7232_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1120974","volume":"14","author":"G Panov","year":"2023","unstructured":"Panov G, Panova P. Obsessive-compulsive symptoms in patient with schizophrenia: the influence of disorganized symptoms, duration of schizophrenia, and drug resistance. Front Psychiatry. 2023;14: 1120974. https:\/\/doi.org\/10.3389\/fpsyt.2023.1120974.","journal-title":"Front Psychiatry"},{"key":"7232_CR19","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1017\/S003329172100492X","volume":"53","author":"K Parkin","year":"2021","unstructured":"Parkin K, et al. Clozapine-related obsessive\u2013compulsive symptoms and their impact on wellbeing: a naturalistic longitudinal study. Psychol Med. 2021;53:2936\u201345. https:\/\/doi.org\/10.1017\/S003329172100492X.","journal-title":"Psychol Med"},{"key":"7232_CR20","doi-asserted-by":"publisher","first-page":"1209077","DOI":"10.3389\/fpsyt.2023.1209077","volume":"14","author":"L Renemane","year":"2023","unstructured":"Renemane L, Rancans E. Case report: Treatment-resistant schizophrenia with auto-aggressive compulsive behavior\u2014successful management with cariprazine. Front Psychiatry. 2023;14:1209077. https:\/\/doi.org\/10.3389\/fpsyt.2023.1209077.","journal-title":"Front Psychiatry"},{"key":"7232_CR21","first-page":"219","volume":"10","author":"F Seedat","year":"2007","unstructured":"Seedat F, et al. Prevalence and clinical characteristics of obsessive-compulsive disorder and obsessive compulsive symptoms in Afrikaner schizophrenia and schizoaffective disorder patients. Afr J Psychiatry. 2007;10:219\u201324.","journal-title":"Afr J Psychiatry"},{"key":"7232_CR22","doi-asserted-by":"publisher","unstructured":"Seow JGHC, Tan DHY, See YM, Yee JY, Ng BT, Tang C, Lee J. Obsessive-compulsive symptoms and disorder in clozapine-treated schizophrenia. Span J Psychiatry Ment Health. 31 octobre 2023 : S2950\u20132853(23)00054\u20136. https:\/\/doi.org\/10.1016\/j.sjpmh.2023.10.001.","DOI":"10.1016\/j.sjpmh.2023.10.001"},{"issue":"Suppl 1","key":"7232_CR23","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.4103\/psychiatry.IndianJPsychiatry_527_18","volume":"61","author":"LP Sharma","year":"2019","unstructured":"Sharma LP, Reddy YCJ. Obsessive-compulsive disorder comorbid with schizophrenia and bipolar disorder. Indian J Psychiatry. 2019;61(Suppl 1):S140\u20138. https:\/\/doi.org\/10.4103\/psychiatry.IndianJPsychiatry_527_18. (PMID: 30745688).","journal-title":"Indian J Psychiatry"},{"key":"7232_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00099","volume":"4","author":"F Schirmbeck","year":"2013","unstructured":"Schirmbeck F, Zink M. Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors. Front Pharmacol. 2013;4: 99. https:\/\/doi.org\/10.3389\/fphar.2013.00099.","journal-title":"Front Pharmacol"},{"issue":"8","key":"7232_CR25","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3390\/biom13081220.PMID:37627285;PMCID:PMC10452784","volume":"13","author":"L Vellucci","year":"2023","unstructured":"Vellucci L, Ciccarelli M, Buonaguro EF, Fornaro M, D\u2019Urso G, De Simone G, Iasevoli F, Barone A, de Bartolomeis A. The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia. Biomolecules. 2023;13(8):1220. https:\/\/doi.org\/10.3390\/biom13081220.PMID:37627285;PMCID:PMC10452784.","journal-title":"Biomolecules"},{"key":"7232_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.schres.2023.10.003","volume":"268","author":"H Verdoux","year":"2024","unstructured":"Verdoux H, Quiles C, de Leon J. Optimizing antidepressant and clozapine co-prescription in clinical practice: A systematic review and expert recommendations. Schizophr Res. 2024;268:243\u201351. https:\/\/doi.org\/10.1016\/j.schres.2023.10.003.","journal-title":"Schizophr Res"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07232-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07232-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07232-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:34:57Z","timestamp":1772714097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-025-07232-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7232"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07232-1","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}